<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:00:17Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9437555" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9437555</identifier>
        <datestamp>2022-09-09</datestamp>
        <setSpec>jintaidssoc</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jia225990" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1758-2652</journal-id>
              <journal-id journal-id-type="publisher-id">JIA2</journal-id>
              <journal-title-group>
                <journal-title>Journal of the International AIDS Society</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1758-2652</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9437555</article-id>
              <article-id pub-id-type="pmcid">PMC9437555</article-id>
              <article-id pub-id-type="pmc-uid">9437555</article-id>
              <article-id pub-id-type="pmid">36052462</article-id>
              <article-id pub-id-type="doi">10.1002/jia2.25990</article-id>
              <article-id pub-id-type="publisher-id">JIA225990</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self‐report in predicting viral suppression in a cluster‐randomized trial</article-title>
                <alt-title alt-title-type="left-running-head">Kizito S et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jia225990-cr-0001" contrib-type="author">
                  <name>
                    <surname>Kizito</surname>
                    <given-names>Samuel</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0002" contrib-type="author">
                  <name>
                    <surname>Namuwonge</surname>
                    <given-names>Flavia</given-names>
                  </name>
                  <xref rid="jia225990-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0003" contrib-type="author">
                  <name>
                    <surname>Brathwaite</surname>
                    <given-names>Rachel</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0004" contrib-type="author">
                  <name>
                    <surname>Neilands</surname>
                    <given-names>Torsten B.</given-names>
                  </name>
                  <xref rid="jia225990-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0005" contrib-type="author">
                  <name>
                    <surname>Nabunya</surname>
                    <given-names>Proscovia</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0006" contrib-type="author">
                  <name>
                    <surname>Bahar</surname>
                    <given-names>Ozge Sensoy</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0007" contrib-type="author">
                  <name>
                    <surname>Damulira</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0008" contrib-type="author">
                  <name>
                    <surname>Mwebembezi</surname>
                    <given-names>Abel</given-names>
                  </name>
                  <xref rid="jia225990-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0009" contrib-type="author">
                  <name>
                    <surname>Mellins</surname>
                    <given-names>Claude</given-names>
                  </name>
                  <xref rid="jia225990-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0010" contrib-type="author">
                  <name>
                    <surname>McKay</surname>
                    <given-names>Mary M.</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225990-cr-0011" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Ssewamala</surname>
                    <given-names>Fred M.</given-names>
                  </name>
                  <xref rid="jia225990-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>fms1@wustl.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jia225990-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">International Center for Child Health and Development, Brown School</named-content>
                <institution>Washington University in St. Louis</institution>
                <city>St. Louis</city>
                <named-content content-type="country-part">Missouri</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225990-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <institution>International Center for Child Health and Development</institution>
                <city>Masaka</city>
                <country country="UG">Uganda</country>
              </aff>
              <aff id="jia225990-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Division of Prevention Science</named-content>
                <institution>University of California</institution>
                <city>San Francisco</city>
                <named-content content-type="country-part">California</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225990-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <institution>Reach the Youth Uganda</institution>
                <city>Kampala</city>
                <country country="UG">Uganda</country>
              </aff>
              <aff id="jia225990-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Columbia University, HIV Center for Clinical and Behavioral Studies</named-content>
                <named-content content-type="organisation-division">Department of Psychiatry</named-content>
                <institution>New York State Psychiatric Institute and Columbia University</institution>
                <city>New York City</city>
                <named-content content-type="country-part">New York</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold>: Professor Fred M. Ssewamala, International Center for Child Health and Development, Brown School, Washington University in St. Louis, MO, 63130, U.S.A. (<email>fms1@wustl.edu</email>)<break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>02</day>
                <month>9</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>9</month>
                <year>2022</year>
              </pub-date>
              <volume>25</volume>
              <issue seq="20">9</issue>
              <issue-id pub-id-type="doi">10.1002/jia2.v25.9</issue-id>
              <elocation-id>e25990</elocation-id>
              <history>
                <date date-type="received">
                  <day>19</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 International AIDS Society.-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Journal of the International AIDS Society</italic> published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JIA2-25-e25990.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="jia225990-sec-0010">
                  <title>Introduction</title>
                  <p>Optimal antiretroviral therapy (ART) adherence is crucial for improved patient outcomes; however, ART adherence among adolescents living with HIV (ALHIV) is low. Also, the performance of various adherence measures among ALHIV is under contention. We monitored ART adherence and compared Self‐report (SR) and Wisepill electronic monitoring (EM) performance in measuring ART adherence and predicting HIV viral suppression among ALHIV.</p>
                </sec>
                <sec id="jia225990-sec-0020">
                  <title>Methods</title>
                  <p>Between January 2014 and December 2015, we recruited 702 ALHIV aged 10–16 years into our cluster‐randomized controlled trial (2012–2018) in 39 clinics in Uganda. The intervention included a long‐term savings child development account, four micro‐enterprise workshops and 12 mentorship sessions. Using the entire sample, we performed multilevel logistic regression to predict monthly ART adherence trends for the first year of follow‐up. Since it is possible that the intervention had different effects on SR and EM adherence, we used participants in the control arm only to compare adherence using SR and EM and to calculate their sensitivity and specificity in predicting viral suppression.</p>
                </sec>
                <sec id="jia225990-sec-0030">
                  <title>Results</title>
                  <p>There was a significant decline in adherence for each month throughout the entire follow‐up period regardless of the group assigned. Good ART adherence was measured at 79.2% (75.2–82.6%) and 97.0% (95.4–98.1%) using EM and SR, respectively. Overall, 64.3% (60.6–67.9%) had suppressed viral loads. The specificities for EM and SR in predicting viral non‐suppression were 80.4% (73.6–85.7%) and 96.7% (93.3–98.4%), while the sensitivities were 22.9% (15.0–33.3%) and 1.8% (0.4–6.9%), respectively. The area under the curve was low for both EM and SR, at 53.6% (45.7–61.5%) and 56.2% (53.2–59.3%), respectively. There was high agreement (78%) between SR and EM in monitoring adherence.</p>
                </sec>
                <sec id="jia225990-sec-0040">
                  <title>Conclusions</title>
                  <p>Our findings highlighted the need for strategies for sustained optimal adherence. SR and EM measure adherence with a considerable agreement; however, neither is an accurate predictor of virological outcome. There is still a need for an acceptable, feasible and affordable method that predicts viral suppression among ALHIV.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jia225990-kwd-0001">ART adherence</kwd>
                <kwd id="jia225990-kwd-0002">economic empowerment</kwd>
                <kwd id="jia225990-kwd-0003">real‐time monitoring</kwd>
                <kwd id="jia225990-kwd-0004">HIV/AIDS</kwd>
                <kwd id="jia225990-kwd-0005">adolescents</kwd>
                <kwd id="jia225990-kwd-0006">sub‐Saharan Africa</kwd>
              </kwd-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="6"/>
                <page-count count="12"/>
                <word-count count="6990"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>September 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:02.09.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group>
                <fn id="jia225990-note-0001">
                  <p>Clinical Trials Number: NCT01790373</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <sec id="jia225990-sec-0050">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Most children born with HIV survive into adolescence and adulthood due to expanded access to antiretroviral therapy (ART) [<xref rid="jia225990-bib-0001" ref-type="bibr">1</xref>, <xref rid="jia225990-bib-0002" ref-type="bibr">2</xref>]. This, alongside horizontal transmission, has resulted in the number of adolescents living with HIV (ALHIV) to increase in the last decade. Approximately 1.5 million ALHIV reside in sub‐Saharan Africa, accounting for 88% of the global population of ALHIV [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0004" ref-type="bibr">4</xref>, <xref rid="jia225990-bib-0007" ref-type="bibr">7</xref>]. In Uganda, of the 1.2 million people living with HIV, 150,000 are children and adolescents below 15 years [<xref rid="jia225990-bib-0004" ref-type="bibr">4</xref>].</p>
              <p>Optimal ART adherence is associated with better clinical and immunological outcomes, such as preventing HIV drug resistance, reducing HIV transmission and prolonging survival. Compared to adults, ALHIV have lower ART adherence and poorer outcomes [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0005" ref-type="bibr">5</xref>, <xref rid="jia225990-bib-0006" ref-type="bibr">6</xref>, <xref rid="jia225990-bib-0028" ref-type="bibr">28</xref>, <xref rid="jia225990-bib-0038" ref-type="bibr">38</xref>], resulting in increased AIDS‐related deaths in this population [<xref rid="jia225990-bib-0007" ref-type="bibr">7</xref>]. In 2019 alone, globally, 34,000 adolescents died from AIDS and AIDS‐related causes [<xref rid="jia225990-bib-0007" ref-type="bibr">7</xref>]. In Uganda, viral suppression among ALHIV is 32.5% and 44.9% for males and females, respectively [5]. Gaps still exist in research on adherence in this group. For instance, although electronic monitoring (EM) allows objective measurement of ART adherence prospectively, few studies employing EM have focused exclusively on adolescents from low‐income backgrounds [<xref rid="jia225990-bib-0008" ref-type="bibr">8</xref>]. Yet, understanding the trend in adherence is crucial in informing the development of focused interventions to improve adherence.</p>
              <p>Self‐reports (SR) and EM are two of the various measures of ART adherence [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0009" ref-type="bibr">9</xref>, <xref rid="jia225990-bib-0010" ref-type="bibr">10</xref>, <xref rid="jia225990-bib-0011" ref-type="bibr">11</xref>, <xref rid="jia225990-bib-0029" ref-type="bibr">29</xref>, <xref rid="jia225990-bib-0030" ref-type="bibr">30</xref>, <xref rid="jia225990-bib-0039" ref-type="bibr">39</xref>, <xref rid="jia225990-bib-0040" ref-type="bibr">40</xref>]. Although these measures perform well in adults [<xref rid="jia225990-bib-0011" ref-type="bibr">11</xref>, <xref rid="jia225990-bib-0012" ref-type="bibr">12</xref>], their performance in ALHIV is variable. For example, in young adolescents, the responsibility of ensuring adherence lies on both the ALHIV and the caregiver [<xref rid="jia225990-bib-0013" ref-type="bibr">13</xref>, <xref rid="jia225990-bib-0014" ref-type="bibr">14</xref>, <xref rid="jia225990-bib-0041" ref-type="bibr">41</xref>, <xref rid="jia225990-bib-0042" ref-type="bibr">42</xref>]. Therefore, using SR to study adherence in this age group requires consideration of both the ALHIV and the caretaker. However, SR is often administered to the adolescent alone, without considering the caretaker. Also, because adolescents are still developing cognitively, their reporting behaviours may differ from those of adults [<xref rid="jia225990-bib-0013" ref-type="bibr">13</xref>]. SR is subject to recall and social desirability biases leading to over‐estimation of adherence [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0015" ref-type="bibr">15</xref>]. EM measures are costly, and usually require reliable telephone network connectivity [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0015" ref-type="bibr">15</xref>]. There is a need to understand how these measures perform in monitoring adherence and predicting viral suppression in resource‐limited settings. Our paper had two main aims: (1) to model the monthly changes in the prevalence of EM adherence to ART and (2) to compare the performance of SR and EM ART adherence in predicting HIV viral suppression among ALHIV in a resource‐limited setting.</p>
            </sec>
            <sec id="jia225990-sec-0060">
              <label>2</label>
              <title>METHODS</title>
              <sec id="jia225990-sec-0070">
                <label>2.1</label>
                <title>Study design</title>
                <p>This paper utilized data from a 5‐year NICHD‐funded cluster‐randomized controlled trial (Suubi+Adherence study) that ran between 2012 and 2018. The study examined the impact of a family‐based economic empowerment intervention on HIV treatment adherence among ALHIV. The intervention package had three components including: (1) a child development account for long‐term saving, (2) four microenterprise workshops training participants and their families on how to save money and start a family business, and (3) 12 mentorship sessions addressing financial planning, business development and setting up short‐ and long‐term goals. The workshops were provided to the participants and their families, while the mentorship sessions were offered for the adolescents only. Adherence assessments were conducted at baseline, 12‐, 24‐, 36‐ and 48‐months follow‐ups. The details have been published in the study protocol and other International Center for Child Health and Development publications [<xref rid="jia225990-bib-0016" ref-type="bibr">16</xref>, <xref rid="jia225990-bib-0017" ref-type="bibr">17</xref>, <xref rid="jia225990-bib-0043" ref-type="bibr">43</xref>, <xref rid="jia225990-bib-0044" ref-type="bibr">44</xref>].</p>
              </sec>
              <sec id="jia225990-sec-0080">
                <label>2.2</label>
                <title>Study setting</title>
                <p>Participants were recruited from health clinics located in the Greater Masaka region in Uganda. The area reports HIV prevalence rates of up to 12%, which is higher than the national prevalence [<xref rid="jia225990-bib-0018" ref-type="bibr">18</xref>]. Clinics were included in the study if they were accredited to provide HIV care.</p>
              </sec>
              <sec id="jia225990-sec-0090">
                <label>2.3</label>
                <title>Study population</title>
                <p>Between January 2014 and December 2015, we recruited 702 HIV‐positive adolescents (control = 344 and intervention = 358) and followed them up for 4 years. Briefly, to be eligible for enrolment into the study, one had to be HIV positive (adolescent was tested and had confirmation from the medical report) and aware of their status, between ages 10 and 16 years, living within a family and on ART. These patients visited the clinic monthly as part of the routine clinic procedures. When modelling the monthly changes in ART adherence, we included all the participants irrespective of the study group. On the other hand, to compare the performance of SR and EM in predicting HIV viral suppression, we included only participants in the control group.</p>
              </sec>
              <sec id="jia225990-sec-0100">
                <label>2.4</label>
                <title>Randomization</title>
                <p>Initially, 40 clinics were randomized into the two study arms using the restricted randomization technique. However, before data collection started, one clinic was closed by the district health officials because it lacked proper operational licensure. This clinic was subsequently dropped from the study leaving 39 clinics (19 clinics in the control arm and 20 clinics in the intervention arm) (Figure <xref rid="jia225990-fig-0001" ref-type="fig">1</xref>). All the participants in a clinic received the same intervention determined by the study arm in which the clinic was randomized.</p>
                <fig position="float" fig-type="Figure" id="jia225990-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <p>CONSORT flow chart for the Suubi+Adherence study (2012–2018). In the current study, we followed up the participants for the first year of the study. To answer the first aim of our current study, we included participants from both study groups. For the second study aim, we only included participants in the control group and used measurements taken at 1 year of follow‐up to compare the performance of SR and EM in monitoring adherence and predicting viral suppression. In the intervention group, 342 of the 356 participants completed evaluation at the end of the first year. Of the 16 participants who did not complete the evaluation, seven were lost to follow‐up, one participant withdrew from the study and eight participants died. In the control group, 328 of the 344 participants completed evaluation at the end of the first year. The 16 participants who did not complete the evaluation included 13 participants who were lost to follow‐up, two participants who withdrew from the study and one participant who died.</p>
                  </caption>
                  <graphic xlink:href="JIA2-25-e25990-g002" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
            </sec>
            <sec id="jia225990-sec-0110">
              <label>3</label>
              <title>MEASURES</title>
              <sec id="jia225990-sec-0120">
                <label>3.1</label>
                <title>Adherence measures</title>
                <sec id="jia225990-sec-0130">
                  <label>3.1.1</label>
                  <title>Electronic adherence monitoring</title>
                  <p>Participants were provided with a Wisepill adherence monitoring device [<xref rid="jia225990-bib-0019" ref-type="bibr">19</xref>, <xref rid="jia225990-bib-0020" ref-type="bibr">20</xref>] connected to a mobile telecommunications network. Whenever a patient opened the device, it sent a signal to a central server. This signal was denoted as “intake” and was a proxy for a dose taken. Each time the device was not opened, it registered a signal denoted “heartbeat,” which indicated that the device was working, but it was not opened. A signal denoted “none” was only sent when the device was malfunctioning. We received daily adherence information from the participants’ Wisepill device. A missed dose was coded with 0, and a dose taken was coded as 1. We aggregated the daily adherence data to generate monthly adherence. Using the 2020 Consolidated Guidelines for the Prevention and Treatment of HIV in Uganda [<xref rid="jia225990-bib-0021" ref-type="bibr">21</xref>], we dichotomized adherence into good and poor. The guidelines define poor ART adherence as missing ART for more than 4 days a month. At analysis, the few times the devices were malfunctioning were treated as missing data. Patients opened their Wisepill device several times a day for the first few days of receiving the device. As a result, the devices transmitted numerous signals every day for most of the first week. Therefore, due to concerns regarding the reliability of the device opening data during the initial usage period, we excluded the data from the first week after receiving the Wisepill device.  After the first week, for instances where the participants opened the Wisepill device more than once for a prescribed dose, we considered only the first opening and ignored the subsequent openings.</p>
                </sec>
                <sec id="jia225990-sec-0140">
                  <label>3.1.2</label>
                  <title>Self‐reported ART adherence</title>
                  <p>Each participant was asked to recall how many days they had missed taking at least one of the doses of their HIV medication in the preceding 30 days. Specifically, the participant was asked, “<italic toggle="yes">In the last 30 days, on how many days did you miss at least one dose of your HIV medications?</italic>” This measure has been previously used [<xref rid="jia225990-bib-0016" ref-type="bibr">16</xref>, <xref rid="jia225990-bib-0017" ref-type="bibr">17</xref>]. We dichotomized the adherence into good and poor adherence based on missing at least one dose of ART for more than 4 days in a month [<xref rid="jia225990-bib-0021" ref-type="bibr">21</xref>].</p>
                </sec>
                <sec id="jia225990-sec-0150">
                  <label>3.1.3</label>
                  <title>Viral load</title>
                  <p>The viral loads were quantified using the Abbott RealTime HIV‐1 RNA PCR, version 5.00. The viral load was dichotomized into suppressed (&lt;50 copies per ml) and unsuppressed (≥50 copies/ml) [<xref rid="jia225990-bib-0022" ref-type="bibr">22</xref>].</p>
                </sec>
                <sec id="jia225990-sec-0160">
                  <label>3.1.4</label>
                  <title>Baseline characteristics</title>
                  <p>We collected information about socio‐demographic characteristics, including, sex (males vs. females) and orphanhood status (not orphan vs. single orphan vs. double orphan). We also collected treatment‐related information, including the antiretrovirals (ARV) treatment regimen (first vs. second vs. third line), the number of pills taken per day (less than two vs. two to four vs. more than four) and the frequency of taking the ART in a day (once vs. twice).</p>
                </sec>
              </sec>
              <sec id="jia225990-sec-0170">
                <label>3.2</label>
                <title>Data analysis</title>
                <p>Data were analysed using Stata version 15.1. We summarized numerical data using means and standard deviations, and categorical data using percentages. We compared baseline socio‐demographic and treatment characteristics between the intervention and control arm (Table <xref rid="jia225990-tbl-0001" ref-type="table">1</xref>). Depending on the distribution, we used survey estimator analogs of the <italic toggle="yes">t</italic>‐test or a Mann–Whitney‐U test for the numerical data and the Rao–Scott adjusted chi‐square test for categorical data. Of the 702 participants, 103 did not receive a Wisepill device and were not included in the analysis for aim one (modelling the ART adherence trends) Seventy‐eight of the participants without a Wisepill device were randomized to the control group. We performed subgroup analysis based on age, sex, orphanhood status, ARV regimen, number of pills prescribed and frequency of taking ART. We also performed a sensitivity analysis for various SR, EM and viral load cut‐off values.</p>
                <table-wrap position="float" id="jia225990-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline characteristics of 702 adolescents living with HIV in Uganda</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" rowspan="1" colspan="1">Total sample <italic toggle="yes">n</italic> = 702 (%)</th>
                        <th align="center" rowspan="1" colspan="1">Control <italic toggle="yes">n</italic> = 344 (%)</th>
                        <th align="center" rowspan="1" colspan="1">Intervention <italic toggle="yes">n</italic> = 358 (%)</th>
                        <th align="char" rowspan="1" colspan="1"/>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Female</td>
                        <td align="char" rowspan="1" colspan="1">339 (56.3)</td>
                        <td align="char" rowspan="1" colspan="1">174 (50.1)</td>
                        <td align="char" rowspan="1" colspan="1">165 (64.0)</td>
                        <td align="char" rowspan="1" colspan="1">0.783</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age in completed years (mean ± SD)</td>
                        <td align="center" rowspan="1" colspan="1">12.4 ± 1.98</td>
                        <td align="center" rowspan="1" colspan="1">12.4 ± 1.97</td>
                        <td align="center" rowspan="1" colspan="1">12.5 ± 1.99</td>
                        <td align="char" rowspan="1" colspan="1">0.493</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Orphanhood status<xref rid="jia225990-tbl1-note-0002" ref-type="table-fn"><sup>a</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Both parents are deceased</td>
                        <td align="char" rowspan="1" colspan="1">182 (26.4)</td>
                        <td align="char" rowspan="1" colspan="1">95 (28.0)</td>
                        <td align="char" rowspan="1" colspan="1">87 (24.8)</td>
                        <td align="char" rowspan="1" colspan="1">0.537</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">One parent is still alive</td>
                        <td align="char" rowspan="1" colspan="1">262 (38.0)</td>
                        <td align="char" rowspan="1" colspan="1">129 (38.1)</td>
                        <td align="char" rowspan="1" colspan="1">133 (37.9)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Both parents are alive</td>
                        <td align="char" rowspan="1" colspan="1">246 (35.7)</td>
                        <td align="char" rowspan="1" colspan="1">115 (33.9)</td>
                        <td align="char" rowspan="1" colspan="1">131 (37.3)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">ARV treatment regimen</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">First‐line treatment regimen</td>
                        <td align="char" rowspan="1" colspan="1">438 (62.4)</td>
                        <td align="char" rowspan="1" colspan="1">222 (64.5)</td>
                        <td align="char" rowspan="1" colspan="1">216 (60.3)</td>
                        <td align="char" rowspan="1" colspan="1">0.251</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Second‐line treatment regimen</td>
                        <td align="char" rowspan="1" colspan="1">258 (36.8)</td>
                        <td align="char" rowspan="1" colspan="1">117 (34.0)</td>
                        <td align="char" rowspan="1" colspan="1">141 (39.4)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Third‐line treatment regimen</td>
                        <td align="char" rowspan="1" colspan="1">6 (0.9)</td>
                        <td align="char" rowspan="1" colspan="1">5 (1.5)</td>
                        <td align="char" rowspan="1" colspan="1">1 (0.3)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Number of pills prescribed per day</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Less than 2</td>
                        <td align="char" rowspan="1" colspan="1">445 (63.4)</td>
                        <td align="char" rowspan="1" colspan="1">218 (63.4)</td>
                        <td align="char" rowspan="1" colspan="1">227 (63.4)</td>
                        <td align="char" rowspan="1" colspan="1">0.967</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">2–4</td>
                        <td align="char" rowspan="1" colspan="1">155 (22.1)</td>
                        <td align="char" rowspan="1" colspan="1">77 (22.4)</td>
                        <td align="char" rowspan="1" colspan="1">78 (21.8)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">More than 4 pills</td>
                        <td align="char" rowspan="1" colspan="1">102 (14.5)</td>
                        <td align="char" rowspan="1" colspan="1">49 (14.2)</td>
                        <td align="char" rowspan="1" colspan="1">53 (14.8)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Baseline viral load</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Suppressed (&lt;50 copies/ml)</td>
                        <td align="char" rowspan="1" colspan="1">424 (60.4)</td>
                        <td align="char" rowspan="1" colspan="1">219 (63.7)</td>
                        <td align="char" rowspan="1" colspan="1">205 (57.3)</td>
                        <td align="char" rowspan="1" colspan="1">0.083</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Not suppressed (≥50 copies/ml)</td>
                        <td align="char" rowspan="1" colspan="1">278 (39.6)</td>
                        <td align="char" rowspan="1" colspan="1">125 (36.3)</td>
                        <td align="char" rowspan="1" colspan="1">153 (42.7)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Frequency of medication</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Once a day</td>
                        <td align="char" rowspan="1" colspan="1">75 (12.7)</td>
                        <td align="char" rowspan="1" colspan="1">36 (12.4)</td>
                        <td align="char" rowspan="1" colspan="1">39 (13.0)</td>
                        <td align="char" rowspan="1" colspan="1">0.622</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">More than once a day</td>
                        <td align="char" rowspan="1" colspan="1">515 (87.3)</td>
                        <td align="char" rowspan="1" colspan="1">254 (87.6)</td>
                        <td align="char" rowspan="1" colspan="1">261 (87.0)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225990-tbl1-note-0001">
                      <p>Abbreviation: SD, standard deviation.</p>
                    </fn>
                    <fn id="jia225990-tbl1-note-0002">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Some participants (12) had missing information on orphanhood status.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <sec id="jia225990-sec-0180">
                  <label>3.2.1</label>
                  <title>Multilevel regression analysis</title>
                  <p>To longitudinally explore the effect of the intervention on EM ART adherence, we performed multilevel logistic regression models using the <italic toggle="yes">melogit</italic> command. We estimated the margins (i.e. predicted probabilities) for our model and then generated a margins plot for the predicted adherence against time. After ruling out group‐time interaction through running contrasts of marginal predictions, we ran further contrast commands to determine whether the change in adherence over time was significant. Statistical significance for all effects was evaluated at alpha = 0.05.</p>
                </sec>
                <sec id="jia225990-sec-0190">
                  <label>3.2.2</label>
                  <title>Agreement between measures of adherence</title>
                  <p>In comparing the performance of the SR and EM adherence in predicting viral suppression, we included only participants in the control arm of the parent study. We excluded participants in the intervention arm to ensure that any observed differences in adherence were not attributed to the intervention. We used viral load, SR and EM adherence data collected during the 12th month of follow‐up. This way, we ensured that we compared results for measures collected at the same time point. We calculated the percentage agreement between the three tests and the Kappa statistic to determine whether the observed percentage agreement was not due to chance. As observed in our data, whenever there is skewness in the data compared, Kappa statistic is prone to the “paradox of kappa,” whereby the kappa values are so low despite high observed agreement [<xref rid="jia225990-bib-0023" ref-type="bibr">23</xref>]. We employed the adjusted coefficient (AC<sub>1</sub>) proposed by Gwet in 2008, which adjusts for the “paradox of Kappa” bias [<xref rid="jia225990-bib-0024" ref-type="bibr">24</xref>].</p>
                </sec>
                <sec id="jia225990-sec-0200">
                  <label>3.2.3</label>
                  <title>Area under the curve</title>
                  <p>We determined the sensitivity and specificity of SR and EM adherence in predicting viral non‐suppression; we fitted a model to generate the area under the curve (AUC) and associated bootstrapped 95% confidence intervals using the cluster bootstrap to control for clustering at the clinic level. We included a subgroup analysis among young (below 14 years) and older (14–16 years) adolescents. AUC below 70% shows the test is poor, while values of 70–80%, 80–90% and above 90% represent acceptable, excellent and outstanding test performances, respectively [<xref rid="jia225990-bib-0025" ref-type="bibr">25</xref>]. We plotted marginal receiver‐operator curve (ROC) curves for SR and EM adherence in predicting viral outcomes.</p>
                </sec>
              </sec>
              <sec id="jia225990-sec-0210">
                <label>3.3</label>
                <title>Ethical considerations</title>
                <p>The study was approved by the Makerere University School of Public Health Research and Ethics committee (Protocol #210) and the Uganda National Council for Science and Technology (UNCST, SS 2969). Also, the study received approval from the Columbia University Review Board (AAAK3852). Suubi+Adherence study was registered at ClinicalTrials.gov (#NCT01790373). Adolescents provided informed written assent, and caregivers provided written consent before participating in the study. All study staff received research ethics training in Good Clinical Practice or online Collaborative Institutional Training Initiative.</p>
              </sec>
            </sec>
            <sec id="jia225990-sec-0220">
              <label>4</label>
              <title>RESULTS</title>
              <sec id="jia225990-sec-0230">
                <label>4.1</label>
                <title>Socio‐demographic characteristics</title>
                <p>Table <xref rid="jia225990-tbl-0001" ref-type="table">1</xref> presents the baseline socio‐demographic characteristics of the study population. These characteristics were comparable between the control and intervention arms. Overall, the sample comprised 56.3% females (<italic toggle="yes">n</italic> = 339), and the mean age was 12.4 years. Regarding orphanhood status, 38.0% (<italic toggle="yes">n</italic> = 262) had lost one parent, while 35.7% (<italic toggle="yes">n</italic> = 246) had both parents alive. At baseline, 60.4% (<italic toggle="yes">n</italic> = 424) had suppressed viral loads. There were no significant differences in the distribution of baseline characteristics based on viral load suppression (Table <xref rid="jia225990-tbl-0002" ref-type="table">2</xref>).</p>
                <table-wrap position="float" id="jia225990-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Distribution of participant characteristics based on viral suppression</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr>
                        <th colspan="4" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Viral load; <italic toggle="yes">N</italic> (percentage)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" rowspan="1" colspan="1">Suppressed</th>
                        <th align="center" rowspan="1" colspan="1">Unsuppressed</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Female</td>
                        <td align="char" rowspan="1" colspan="1">245 (57.8)</td>
                        <td align="char" rowspan="1" colspan="1">151 (54.3)</td>
                        <td align="left" rowspan="1" colspan="1">0.365</td>
                      </tr>
                      <tr>
                        <td colspan="4" align="left" rowspan="1">Age in completed years</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">10–13 years</td>
                        <td align="char" rowspan="1" colspan="1">294 (69.4)</td>
                        <td align="char" rowspan="1" colspan="1">183 (65.8)</td>
                        <td align="left" rowspan="1" colspan="1">0.329</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">14–16 years</td>
                        <td align="char" rowspan="1" colspan="1">130 (30.7)</td>
                        <td align="char" rowspan="1" colspan="1">95 (34.2)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="4" align="left" rowspan="1">Orphanhood status</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Both parents are deceased</td>
                        <td align="char" rowspan="1" colspan="1">104 (24.9)</td>
                        <td align="char" rowspan="1" colspan="1">78 (28.7)</td>
                        <td align="left" rowspan="1" colspan="1">0.420</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">One parent is still alive</td>
                        <td align="char" rowspan="1" colspan="1">158 (37.8)</td>
                        <td align="char" rowspan="1" colspan="1">104 (38.2)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Both parents are alive</td>
                        <td align="char" rowspan="1" colspan="1">156 (37.2)</td>
                        <td align="char" rowspan="1" colspan="1">90 (33.1)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="4" align="left" rowspan="1">ART regimen</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">First‐line treatment regimen</td>
                        <td align="char" rowspan="1" colspan="1">275 (64.9)</td>
                        <td align="char" rowspan="1" colspan="1">163 (58.6)</td>
                        <td align="left" rowspan="1" colspan="1">0.096</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Second and third regimen</td>
                        <td align="char" rowspan="1" colspan="1">149 (35.1)</td>
                        <td align="char" rowspan="1" colspan="1">115 (41.4)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="4" align="left" rowspan="1">Frequency of medication</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Once a day</td>
                        <td align="char" rowspan="1" colspan="1">46 (12.3)</td>
                        <td align="char" rowspan="1" colspan="1">31 (13.5)</td>
                        <td align="left" rowspan="1" colspan="1">0.667</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">More than once a day</td>
                        <td align="char" rowspan="1" colspan="1">327 (87.7)</td>
                        <td align="char" rowspan="1" colspan="1">198 (86.5)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225990-tbl2-note-0001">
                      <p>Abbreviation: ART, antiretroviral therapy.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225990-sec-0240">
                <label>4.2</label>
                <title>ART adherence</title>
                <p>The multi‐level regression model for predicting ART adherence measured using the Wisepill device showed that there was no significant difference in adherence between the intervention and control arm β = 0.339 (95% CI: –1.094 to 1.771), <italic toggle="yes">p</italic> = 0.643. Also, compared to the first month, there was a significant decline in adherence for each month throughout the entire follow‐up period regardless of the group assigned. Compared to baseline, there was significantly lower adherence at each follow‐up point, irrespective of the study group (Table <xref rid="jia225990-tbl-0003" ref-type="table">3</xref>). The findings are illustrated in Figure <xref rid="jia225990-fig-0002" ref-type="fig">2</xref>. The monthly adherence gradually declined for the first 5 months of follow‐up, after which it showed monthly fluctuations for the rest of the follow‐up time.</p>
                <table-wrap position="float" id="jia225990-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Monthly trends in ART adherence among adolescents with HIV measured using Wisepill technology for 1 year among ALHIV</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="char" rowspan="1" colspan="1"/>
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">95% Confidence interval</th>
                        <th align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variable</th>
                        <th align="center" rowspan="1" colspan="1">Coefficient</th>
                        <th align="center" rowspan="1" colspan="1">Lower limit</th>
                        <th align="center" rowspan="1" colspan="1">Upper limit</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Time in months</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">Reference</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">2</td>
                        <td align="char" rowspan="1" colspan="1">−1.202</td>
                        <td align="char" rowspan="1" colspan="1">−2.090</td>
                        <td align="char" rowspan="1" colspan="1">−0.313</td>
                        <td align="char" rowspan="1" colspan="1">0.008</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">3</td>
                        <td align="char" rowspan="1" colspan="1">−1.787</td>
                        <td align="char" rowspan="1" colspan="1">−2.906</td>
                        <td align="char" rowspan="1" colspan="1">−0.668</td>
                        <td align="char" rowspan="1" colspan="1">0.002</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">4</td>
                        <td align="char" rowspan="1" colspan="1">−1.875</td>
                        <td align="char" rowspan="1" colspan="1">−2.808</td>
                        <td align="char" rowspan="1" colspan="1">−0.943</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">5</td>
                        <td align="char" rowspan="1" colspan="1">−2.177</td>
                        <td align="char" rowspan="1" colspan="1">−3.051</td>
                        <td align="char" rowspan="1" colspan="1">−1.304</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">6</td>
                        <td align="char" rowspan="1" colspan="1">−2.217</td>
                        <td align="char" rowspan="1" colspan="1">−3.091</td>
                        <td align="char" rowspan="1" colspan="1">−1.343</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">7</td>
                        <td align="char" rowspan="1" colspan="1">−2.166</td>
                        <td align="char" rowspan="1" colspan="1">−2.930</td>
                        <td align="char" rowspan="1" colspan="1">−1.402</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">8</td>
                        <td align="char" rowspan="1" colspan="1">−2.473</td>
                        <td align="char" rowspan="1" colspan="1">−3.450</td>
                        <td align="char" rowspan="1" colspan="1">−1.496</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">9</td>
                        <td align="char" rowspan="1" colspan="1">−2.373</td>
                        <td align="char" rowspan="1" colspan="1">−3.589</td>
                        <td align="char" rowspan="1" colspan="1">−1.158</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">10</td>
                        <td align="char" rowspan="1" colspan="1">−2.517</td>
                        <td align="char" rowspan="1" colspan="1">−3.797</td>
                        <td align="char" rowspan="1" colspan="1">−1.236</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">11</td>
                        <td align="char" rowspan="1" colspan="1">−1.798</td>
                        <td align="char" rowspan="1" colspan="1">−3.284</td>
                        <td align="char" rowspan="1" colspan="1">−0.670</td>
                        <td align="char" rowspan="1" colspan="1">0.003</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">12</td>
                        <td align="char" rowspan="1" colspan="1">−2.416</td>
                        <td align="char" rowspan="1" colspan="1">−3.717</td>
                        <td align="char" rowspan="1" colspan="1">−1.115</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Group</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Intervention</td>
                        <td align="char" rowspan="1" colspan="1">0.339</td>
                        <td align="char" rowspan="1" colspan="1">−1.094</td>
                        <td align="char" rowspan="1" colspan="1">1.771</td>
                        <td align="char" rowspan="1" colspan="1">0.643</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" rowspan="1">Time and group interaction</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">Reference</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">2</td>
                        <td align="char" rowspan="1" colspan="1">−0.415</td>
                        <td align="char" rowspan="1" colspan="1">−1.639</td>
                        <td align="char" rowspan="1" colspan="1">0.808</td>
                        <td align="char" rowspan="1" colspan="1">0.506</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">3</td>
                        <td align="char" rowspan="1" colspan="1">−0.217</td>
                        <td align="char" rowspan="1" colspan="1">−1.614</td>
                        <td align="char" rowspan="1" colspan="1">1.181</td>
                        <td align="char" rowspan="1" colspan="1">0.761</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">4</td>
                        <td align="char" rowspan="1" colspan="1">−0.091</td>
                        <td align="char" rowspan="1" colspan="1">−1.329</td>
                        <td align="char" rowspan="1" colspan="1">1.147</td>
                        <td align="char" rowspan="1" colspan="1">0.885</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">5</td>
                        <td align="char" rowspan="1" colspan="1">−0.369</td>
                        <td align="char" rowspan="1" colspan="1">−1.726</td>
                        <td align="char" rowspan="1" colspan="1">0.987</td>
                        <td align="char" rowspan="1" colspan="1">0.594</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">6</td>
                        <td align="char" rowspan="1" colspan="1">−0.069</td>
                        <td align="char" rowspan="1" colspan="1">−1.434</td>
                        <td align="char" rowspan="1" colspan="1">1.296</td>
                        <td align="char" rowspan="1" colspan="1">0.921</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">7</td>
                        <td align="char" rowspan="1" colspan="1">0.573</td>
                        <td align="char" rowspan="1" colspan="1">−0.823</td>
                        <td align="char" rowspan="1" colspan="1">1.968</td>
                        <td align="char" rowspan="1" colspan="1">0.421</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">8</td>
                        <td align="char" rowspan="1" colspan="1">0.021</td>
                        <td align="char" rowspan="1" colspan="1">−1.476</td>
                        <td align="char" rowspan="1" colspan="1">1.518</td>
                        <td align="char" rowspan="1" colspan="1">0.978</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">9</td>
                        <td align="char" rowspan="1" colspan="1">0.190</td>
                        <td align="char" rowspan="1" colspan="1">−1.415</td>
                        <td align="char" rowspan="1" colspan="1">1.794</td>
                        <td align="char" rowspan="1" colspan="1">0.817</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">10</td>
                        <td align="char" rowspan="1" colspan="1">−0.176</td>
                        <td align="char" rowspan="1" colspan="1">−1.819</td>
                        <td align="char" rowspan="1" colspan="1">1.468</td>
                        <td align="char" rowspan="1" colspan="1">0.834</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">11</td>
                        <td align="char" rowspan="1" colspan="1">−0.343</td>
                        <td align="char" rowspan="1" colspan="1">−1.931</td>
                        <td align="char" rowspan="1" colspan="1">1.245</td>
                        <td align="char" rowspan="1" colspan="1">0.672</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">12</td>
                        <td align="char" rowspan="1" colspan="1">−0.116</td>
                        <td align="char" rowspan="1" colspan="1">−1.921</td>
                        <td align="char" rowspan="1" colspan="1">1.689</td>
                        <td align="char" rowspan="1" colspan="1">0.900</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Constant</td>
                        <td align="char" rowspan="1" colspan="1">6.044</td>
                        <td align="char" rowspan="1" colspan="1">4.778</td>
                        <td align="char" rowspan="1" colspan="1">7.311</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Random effects</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <bold>Coefficient</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <bold>Lower limit</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <bold>Upper limit</bold>
                        </td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Clinic variance</td>
                        <td align="char" rowspan="1" colspan="1">0.089</td>
                        <td align="char" rowspan="1" colspan="1">0.014</td>
                        <td align="char" rowspan="1" colspan="1">0.528</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Participant variance</td>
                        <td align="char" rowspan="1" colspan="1">10.610</td>
                        <td align="char" rowspan="1" colspan="1">8.208</td>
                        <td align="char" rowspan="1" colspan="1">13.716</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="jia225990-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <p>Linear prediction of monthly adherence measured using the Wisepill device in the Suubi+Adherence study conducted among ALHIV in Southern Uganda. We fitted a three‐level logistic regression model, with the repeated measures of adherence taking level 1, the participant at level 2 and the clinic at level 3. Vertical bars denote the 95% confidence intervals (CI) for the adherence in each of the months of follow‐up. Optimal adherence meant that a participant took their ART and missed medication on only 4 days or less within the month. A total of 599 ALHIV contributed to 6262 observations over a period of 1 year. EM data were generated daily and were averaged to generate monthly adherences.</p>
                  </caption>
                  <graphic xlink:href="JIA2-25-e25990-g003" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
              <sec id="jia225990-sec-0250">
                <label>4.3</label>
                <title>Agreement between the adherence measures</title>
                <p>Using EM, 79.2% (75.2–82.6%) of the participants had good ART adherence, while 97.0% (95.4–98.1%) reported good adherence with SR. Overall, 64.3% (60.6–67.9%) had suppressed viral loads at the 12th month of follow‐up. We observed statistically significant differences in viral suppression across participants who were prescribed 2 or fewer pills, 2–4 and more than 4 pills per day (<italic toggle="yes">p</italic> = 0.022). Also, the self‐reported adherence was significantly higher in males than females (<italic toggle="yes">p</italic> = 0.05). See Table <xref rid="jia225990-tbl-0004" ref-type="table">4</xref>.</p>
                <table-wrap position="float" id="jia225990-tbl-0004" content-type="Table">
                  <label>Table 4</label>
                  <caption>
                    <p>Adherence to antiretroviral therapy measured at month 12 of follow‐up among adolescents with HIV</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="." span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Viral suppression<xref rid="jia225990-tbl4-note-0001" ref-type="table-fn"><sup>a</sup></xref>
</th>
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Wisepill adherence<xref rid="jia225990-tbl4-note-0003" ref-type="table-fn"><sup>b</sup></xref>
</th>
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Self‐reported adherence<xref rid="jia225990-tbl4-note-0003" ref-type="table-fn"><sup>b</sup></xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variables</th>
                        <th align="center" rowspan="1" colspan="1">Prevalence (95% CI)</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                        <th align="center" rowspan="1" colspan="1">Adherence</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                        <th align="center" rowspan="1" colspan="1">Adherence</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Overall</td>
                        <td align="char" rowspan="1" colspan="1">64.3 (60.6–67.9)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">79.2 (75.2–82.6)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">97.0 (95.4–98.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">Age of adolescent</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">10–13 years</td>
                        <td align="char" rowspan="1" colspan="1">64.9 (60.5–69.2)</td>
                        <td align="char" rowspan="1" colspan="1">0.625</td>
                        <td align="char" rowspan="1" colspan="1">78.1 (73.0–82.4)</td>
                        <td align="char" rowspan="1" colspan="1">0.425</td>
                        <td align="char" rowspan="1" colspan="1">96.8 (94.7–98.0)</td>
                        <td align="char" rowspan="1" colspan="1">0.553</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">14–16 years</td>
                        <td align="char" rowspan="1" colspan="1">63.0 (56.2–69.3)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">81.8 (74.5–86.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">97.6 (94.3–99.0)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">Sex</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Male</td>
                        <td align="char" rowspan="1" colspan="1">62.4 (56.7–67.7)</td>
                        <td align="char" rowspan="1" colspan="1">0.349</td>
                        <td align="char" rowspan="1" colspan="1">80.8 (74.7–85.7)</td>
                        <td align="char" rowspan="1" colspan="1">0.454</td>
                        <td align="char" rowspan="1" colspan="1">95.6 (92.5–97.4)</td>
                        <td align="char" rowspan="1" colspan="1">0.050</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Female</td>
                        <td align="char" rowspan="1" colspan="1">65.9 (60.9–70.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">77.9 (72.5–82.6)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">98.1 (96.1–99.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">Orphanhood</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Double orphan</td>
                        <td align="char" rowspan="1" colspan="1">62.9 (30.1–44.6)</td>
                        <td align="char" rowspan="1" colspan="1">0.704</td>
                        <td align="char" rowspan="1" colspan="1">82.7 (74.8–88.5)</td>
                        <td align="char" rowspan="1" colspan="1">0.407</td>
                        <td align="char" rowspan="1" colspan="1">97.6 (93.9–99.1)</td>
                        <td align="char" rowspan="1" colspan="1">0.708</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">One parent alive</td>
                        <td align="char" rowspan="1" colspan="1">63.3 (57.1–69.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">79.4 (72.9–84.8)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">96.8 (93.7–98.4)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Not orphan</td>
                        <td align="char" rowspan="1" colspan="1">66.4 (60.1–72.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">76.1 (68.8–82.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">97.9 (95.1–99.1)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">ART regimen</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">First line</td>
                        <td align="char" rowspan="1" colspan="1">65.1 (60.4–69.6)</td>
                        <td align="char" rowspan="1" colspan="1">0.265</td>
                        <td align="char" rowspan="1" colspan="1">80.6 (75.6–84.8)</td>
                        <td align="char" rowspan="1" colspan="1">0.336</td>
                        <td align="char" rowspan="1" colspan="1">97.8 (95.8–98.9)</td>
                        <td align="char" rowspan="1" colspan="1">0.131</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Second or third line</td>
                        <td align="char" rowspan="1" colspan="1">63.8 (57.7–69.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">76.9 (70.2–82.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">95.8 (92.5–97.6)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">Pills prescribed per day</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Less than 2</td>
                        <td align="char" rowspan="1" colspan="1">65.5 (60.8–69.9)</td>
                        <td align="char" rowspan="1" colspan="1">0.022</td>
                        <td align="char" rowspan="1" colspan="1">78.5 (73.4–82.8)</td>
                        <td align="char" rowspan="1" colspan="1">0.514</td>
                        <td align="char" rowspan="1" colspan="1">97.8 (95.9–98.9)</td>
                        <td align="char" rowspan="1" colspan="1">0.167</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">2–4</td>
                        <td align="char" rowspan="1" colspan="1">68.8 (61.0–75.7)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">77.7 (68.5–84.8)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">94.8 (89.9–97.4)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">More than 4 pills</td>
                        <td align="char" rowspan="1" colspan="1">52.5 (42.6–62.2)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">84.3 (73.6–91.2)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">97.0 (90.9–99.0)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td colspan="7" align="left" rowspan="1">Frequency of medication</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Once a day</td>
                        <td align="char" rowspan="1" colspan="1">69.4 (57.7–79.1)</td>
                        <td align="char" rowspan="1" colspan="1">0.556</td>
                        <td align="char" rowspan="1" colspan="1">82.0 (70.0–89.8)</td>
                        <td align="char" rowspan="1" colspan="1">0.566</td>
                        <td align="char" rowspan="1" colspan="1">98.6 (90.5–99.8)</td>
                        <td align="char" rowspan="1" colspan="1">0.441</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Twice a day</td>
                        <td align="char" rowspan="1" colspan="1">65.9 (61.7–70.0)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">78.8 (74.5–82.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1">97.0 (95.1–98.2)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225990-tbl4-note-0001">
                      <p>Abbreviation: ART, antiretroviral therapy.</p>
                    </fn>
                    <fn id="jia225990-tbl4-note-0002">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Viral suppression was defined by having a viral load of less than 50 copies/ml.</p>
                    </fn>
                    <fn id="jia225990-tbl4-note-0003">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Good adherence was defined as a patient missing ART on only 4 days or less with in the last 30 days.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>There was 77.7% agreement between SR and EM when monitoring adherence. However, the observed agreement was lower between SR versus viral load and EM versus viral load (64.0% and 61.4%, respectively). The kappa statistic for all three tests was low, ranging from 0.02 to 0.06. However, the agreement coefficients were higher, ranging from 0.4 to 0.8, which suggested moderate to good agreement between the measures. Comparable results were observed in younger (10–13 years) and older (14–16 years) adolescents (Table <xref rid="jia225990-tbl-0005" ref-type="table">5</xref>).</p>
                <table-wrap position="float" id="jia225990-tbl-0005" content-type="Table">
                  <label>Table 5</label>
                  <caption>
                    <p>Agreement between the measures of ART adherence among ALHIV in the control group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Adherence measure<xref rid="jia225990-tbl5-note-0002" ref-type="table-fn"><sup>a</sup></xref>
</th>
                        <th align="center" rowspan="1" colspan="1">Observed agreement</th>
                        <th align="center" rowspan="1" colspan="1">Expected agreement</th>
                        <th align="center" rowspan="1" colspan="1">Adjusted expected agreement</th>
                        <th align="center" rowspan="1" colspan="1">Kappa statistic</th>
                        <th align="center" rowspan="1" colspan="1">Agreement coefficient</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Overall</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Wise pill</td>
                        <td align="char" rowspan="1" colspan="1">61.4%</td>
                        <td align="char" rowspan="1" colspan="1">59.9%</td>
                        <td align="char" rowspan="1" colspan="1">39.3%</td>
                        <td align="char" rowspan="1" colspan="1">0.04</td>
                        <td align="char" rowspan="1" colspan="1">0.364</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">64.0%</td>
                        <td align="char" rowspan="1" colspan="1">64.7%</td>
                        <td align="char" rowspan="1" colspan="1">30.8%</td>
                        <td align="char" rowspan="1" colspan="1">0.02</td>
                        <td align="char" rowspan="1" colspan="1">0.484</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Wise pill versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">77.7%</td>
                        <td align="char" rowspan="1" colspan="1">77.4%</td>
                        <td align="char" rowspan="1" colspan="1">21.0%</td>
                        <td align="char" rowspan="1" colspan="1">0.01</td>
                        <td align="char" rowspan="1" colspan="1">0.716</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Among ALHIV aged 10–13 years</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Wise pill</td>
                        <td align="char" rowspan="1" colspan="1">61.1%</td>
                        <td align="char" rowspan="1" colspan="1">60.3%</td>
                        <td align="char" rowspan="1" colspan="1">39.5%</td>
                        <td align="char" rowspan="1" colspan="1">0.02</td>
                        <td align="char" rowspan="1" colspan="1">0.356</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">66.1%</td>
                        <td align="char" rowspan="1" colspan="1">66.9%</td>
                        <td align="char" rowspan="1" colspan="1">28.7%</td>
                        <td align="char" rowspan="1" colspan="1">0.02</td>
                        <td align="char" rowspan="1" colspan="1">0.590</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Wise pill versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">75.6%</td>
                        <td align="char" rowspan="1" colspan="1">74.9%</td>
                        <td align="char" rowspan="1" colspan="1">23.2%</td>
                        <td align="char" rowspan="1" colspan="1">0.03</td>
                        <td align="char" rowspan="1" colspan="1">0.682</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Among ALHIV aged 14–16 years</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Wise pill</td>
                        <td align="char" rowspan="1" colspan="1">62.0%</td>
                        <td align="char" rowspan="1" colspan="1">58.4%</td>
                        <td align="char" rowspan="1" colspan="1">39.0%</td>
                        <td align="char" rowspan="1" colspan="1">0.09</td>
                        <td align="char" rowspan="1" colspan="1">0.792</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Viral load versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">59.0%</td>
                        <td align="char" rowspan="1" colspan="1">59.4%</td>
                        <td align="char" rowspan="1" colspan="1">33.8%</td>
                        <td align="char" rowspan="1" colspan="1">0.01</td>
                        <td align="char" rowspan="1" colspan="1">0.379</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Wise pill versus Self‐report</td>
                        <td align="char" rowspan="1" colspan="1">82.3%</td>
                        <td align="char" rowspan="1" colspan="1">83.1%</td>
                        <td align="char" rowspan="1" colspan="1">16.2%</td>
                        <td align="char" rowspan="1" colspan="1">0.05</td>
                        <td align="char" rowspan="1" colspan="1">0.789</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225990-tbl5-note-0001">
                      <p>Abbreviation: ALHIV, adolescents living with HIV.</p>
                    </fn>
                    <fn id="jia225990-tbl5-note-0002">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Viral load was fixed at 50 copies/ml cut‐off.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225990-sec-0260">
                <label>4.4</label>
                <title>Sensitivity, specificity and AUC</title>
                <p>We found high specificities of, 80.4% (73.6–85.7%) and 96.7% (93.3–98.4%), for the EM and SR, respectively. The sensitivities for the two tests were 22.9% (15.0–33.3%) and 1.8% (0.4–6.9%), respectively. The AUCs for EM and SR were 53.6% (45.7–61.5%) and 56.2% (53.2–59.3%), respectively. We observed similar results when we performed separate tests for the adolescents aged 10–13 years and those 14–16 years old. Figure <xref rid="jia225990-fig-0003" ref-type="fig">3</xref> shows the ROC for SR and EM in predicting viral non‐suppression (Table <xref rid="jia225990-tbl-0006" ref-type="table">6</xref>).</p>
                <fig position="float" fig-type="Figure" id="jia225990-fig-0003">
                  <label>Figure 3</label>
                  <caption>
                    <p>Area under the receiver‐operator characteristic curve for the prediction of virologic failure using Wisepill (left) and Self‐report (Right) at month 12 of follow‐up. Viral suppression was defined as having a viral load of at least 50 copies per ml. The marginal ROC curves were plotted after running a regression model to estimate the area under the curve. A total of 251 ALHIV contributed data for the EM adherence ROC (left), while 328 ALHIV contributed the data for the SR ROC graph.</p>
                  </caption>
                  <graphic xlink:href="JIA2-25-e25990-g001" position="anchor" id="jats-graphic-5"/>
                </fig>
                <table-wrap position="float" id="jia225990-tbl-0006" content-type="Table">
                  <label>Table 6</label>
                  <caption>
                    <p>The sensitivity and specificity measures of Wisepill and Self‐report methods in predicting viral non‐suppression among ALHIV in the control group</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <col align="char" char="(" span="1"/>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th colspan="5" style="border-bottom:solid 1px #000000" align="center" rowspan="1">Viral load</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Categories</th>
                        <th align="center" rowspan="1" colspan="1">Suppressed</th>
                        <th align="center" rowspan="1" colspan="1">Unsuppressed</th>
                        <th align="center" rowspan="1" colspan="1">Specificity</th>
                        <th align="center" rowspan="1" colspan="1">Sensitivity</th>
                        <th align="center" rowspan="1" colspan="1">AUC (%)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Overall</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Wisepill measure</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">33 (63.5)</td>
                        <td align="char" rowspan="1" colspan="1">19 (36.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">135 (67.8)</td>
                        <td align="char" rowspan="1" colspan="1">64 (32.2)</td>
                        <td align="char" rowspan="1" colspan="1">80.4 (73.6–85.7)</td>
                        <td align="char" rowspan="1" colspan="1">22.9 (15.0–33.3)</td>
                        <td align="char" rowspan="1" colspan="1">53.6 (45.7–61.5)</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Self‐report measure</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">7 (77.8)</td>
                        <td align="char" rowspan="1" colspan="1">2 (22.2)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">208 (65.2)</td>
                        <td align="char" rowspan="1" colspan="1">111 (34.8)</td>
                        <td align="char" rowspan="1" colspan="1">96.7 (93.3–98.4)</td>
                        <td align="char" rowspan="1" colspan="1">1.8 (0.4–6.9)</td>
                        <td align="char" rowspan="1" colspan="1">56.2 (53.2–59.3)</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Age 10–13 years</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Wisepill</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">27 (67.5)</td>
                        <td align="char" rowspan="1" colspan="1">13 (32.5)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">92 (69.7)</td>
                        <td align="char" rowspan="1" colspan="1">40 (30.3)</td>
                        <td align="char" rowspan="1" colspan="1">77.3 (68.8–84.0)</td>
                        <td align="char" rowspan="1" colspan="1">24.5 (14.6–38.1)</td>
                        <td align="char" rowspan="1" colspan="1">54.0 (45.0–63.0)</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Self‐report measure</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">5 (83.3)</td>
                        <td align="char" rowspan="1" colspan="1">1 (16.7)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">153 (67.4)</td>
                        <td align="char" rowspan="1" colspan="1">74 (32.6)</td>
                        <td align="char" rowspan="1" colspan="1">96.8 (92.6–98.7)</td>
                        <td align="char" rowspan="1" colspan="1">1.3 (0.2–9.1)</td>
                        <td align="char" rowspan="1" colspan="1">56.4 (53.6–59.2)</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">Age 14–16 years</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Wisepill measure</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">6 (50.0)</td>
                        <td align="char" rowspan="1" colspan="1">6 (50.0)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">43 (64.2)</td>
                        <td align="char" rowspan="1" colspan="1">24 (35.8)</td>
                        <td align="char" rowspan="1" colspan="1">87.8 (74.9–94.5)</td>
                        <td align="char" rowspan="1" colspan="1">20.0 (8.9–38.9)</td>
                        <td align="char" rowspan="1" colspan="1">51.6 (39.7–63.6)</td>
                      </tr>
                      <tr>
                        <td colspan="6" align="left" rowspan="1">
                          <italic toggle="yes">Self‐report measure</italic>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Poor adherence</td>
                        <td align="char" rowspan="1" colspan="1">2 (66.7)</td>
                        <td align="char" rowspan="1" colspan="1">1 (33.3)</td>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                        <td align="char" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Good adherence</td>
                        <td align="char" rowspan="1" colspan="1">55 (59.8)</td>
                        <td align="char" rowspan="1" colspan="1">37 (40.2)</td>
                        <td align="char" rowspan="1" colspan="1">96.5 (86.7–99.1)</td>
                        <td align="char" rowspan="1" colspan="1">2.6 (0.3–17.4)</td>
                        <td align="char" rowspan="1" colspan="1">54.9 (50.0–59.7)</td>
                      </tr>
                    </tbody>
                  </table>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225990-sec-0270">
                <label>4.5</label>
                <title>Sensitivity analysis</title>
                <p>We conducted sensitivity analysis by performing comparisons of SR and EM using various adherence levels. Specifically, we used percentage adherences of 95%, 90% and 85% for each measure. We also performed analyses at viral load cut‐off values of &lt;1000 copies/ml to denote viral suppression, as defined by the Uganda national HIV guidelines [<xref rid="jia225990-bib-0021" ref-type="bibr">21</xref>]. All the sensitivity analyses yielded comparable results.</p>
              </sec>
            </sec>
            <sec id="jia225990-sec-0280">
              <label>5</label>
              <title>DISCUSSION</title>
              <p>In the context of this randomized controlled trial of ALHIV, we modelled the monthly changes in the EM adherence to ART for 1 year and compared the performance of SR and EM in predicting HIV viral suppression among ALHIV in Southern Uganda. ART adherence gradually declined, with monthly fluctuations, starting in the first month until the last month, and the intervention was not efficacious in improving ART adherence. We also found that only two‐thirds of the participants had achieved viral suppression. Adherence was independent of demographic and treatment‐related factors. While both measures roughly correlated with each other, neither SR nor EM was found to reliably predict viral suppression in this population. Our results add to the understanding of the discrepancy in measuring ART adherence and predicting viral suppression in ALHIV.</p>
              <p>The gradual decline in EM adherence is consistent with previous follow‐up studies among youths [<xref rid="jia225990-bib-0026" ref-type="bibr">26</xref>, <xref rid="jia225990-bib-0027" ref-type="bibr">27</xref>]. One possible explanation for the declining adherence is a loss of interest in using the Wisepill device. Some participants reported to our research assistants that they were not using the Wisepill devices consistently since the devices needed to be charged, while others were afraid to misplace the device. Although not assessed in our study, qualitative studies elsewhere have examined the reasons for the decline in using the Wisepill device. One study highlighted that patients complained about the Wisepill device being conspicuous and bulky [<xref rid="jia225990-bib-0027" ref-type="bibr">27</xref>]. In these instances, patients resorted to keeping their pills elsewhere and continued swallowing them without using the Wisepill device. The declining adherence that we found in our study highlights the need to implement strategies to ensure sustained adherence.</p>
              <p>The high levels of SR and EM adherence among participants in this study were comparable to those reported in studies from similar settings [<xref rid="jia225990-bib-0028" ref-type="bibr">28</xref>, <xref rid="jia225990-bib-0029" ref-type="bibr">29</xref>, <xref rid="jia225990-bib-0030" ref-type="bibr">30</xref>, <xref rid="jia225990-bib-0031" ref-type="bibr">31</xref>]. Because most participants in our study were ART experienced, resilience is a plausible explanation for the high levels of ART adherence. Also, the ALHIV were recruited from HIV clinics, where they receive comprehensive HIV care, including adherence counselling and monitoring. In 2015, Nabukeera‐Barungi et al. found adherence of 87% among a hospital‐based cohort of ALHIV in Uganda, comparable to our findings [<xref rid="jia225990-bib-0032" ref-type="bibr">32</xref>].</p>
              <p>As found elsewhere, SR reported a higher adherence than EM [<xref rid="jia225990-bib-0003" ref-type="bibr">3</xref>, <xref rid="jia225990-bib-0009" ref-type="bibr">9</xref>, <xref rid="jia225990-bib-0033" ref-type="bibr">33</xref>, <xref rid="jia225990-bib-0034" ref-type="bibr">34</xref>, <xref rid="jia225990-bib-0045" ref-type="bibr">45</xref>, <xref rid="jia225990-bib-0046" ref-type="bibr">46</xref>]. SR overestimates adherence, possibly due to social desirability bias and recall biases [<xref rid="jia225990-bib-0015" ref-type="bibr">15</xref>, <xref rid="jia225990-bib-0027" ref-type="bibr">27</xref>]. Both SR and EM had high specificities, low sensitivities and small AUCs. The high specificity with low sensitivity findings is comparable with a study among young adults in China [<xref rid="jia225990-bib-0035" ref-type="bibr">35</xref>]. The high specificity suggests that high SR and EM adherences were good predictors of viral suppression, while low sensitivities meant that both SR and EM performed poorly in predicting participants with unsuppressed viral loads. One explanation for the poor prediction of viral non‐suppression is that other mechanisms could be responsible for viral non‐suppression, such as drug resistance, drug interactions and drug absorption and metabolism problems [<xref rid="jia225990-bib-0036" ref-type="bibr">36</xref>, <xref rid="jia225990-bib-0037" ref-type="bibr">37</xref>]. The low AUCs suggest that both SE and EM are less reliable predictors of viral outcomes among ALHIV. Patient‐level factors, such as age, did not influence SR and EM performance. Although SR is prone to several biases, we have demonstrated that its performance is comparable to that of EM [<xref rid="jia225990-bib-0027" ref-type="bibr">27</xref>]. Our results imply that in settings with limited access to electronic adherence measures, SR can be used to monitor adherence among ALHIV with comparable accuracy.</p>
              <p>SR and EM agreed 78% of the time while categorizing participants (adherent or non‐adherent) and only disagreed 22% of the time. The kappa statistic was low, at 0.01, implying that this agreement could be by chance. The low kappa (despite a high level of agreement between SR and EM) was explained by the skewed nature of adherence as measured by both SR and EM, whereby most participants reported good adherence [<xref rid="jia225990-bib-0023" ref-type="bibr">23</xref>]. When we adjusted for this bias, we observed a higher agreement coefficient of 0.72, which suggested good agreement between the two measures. There was a moderate agreement between viral load and each of the two adherence measures, SR and EM. Due to the variation in adherence rates during the follow‐up time, it is possible that the observed agreement between the adherence measures and the predication of viral suppression was affected by the time point that we used in making the inferential analyses. Consistent with other studies, in our study, a considerable number of the patients with non‐suppressed viral loads had good adherence and vice versa [<xref rid="jia225990-bib-0006" ref-type="bibr">6</xref>]. The results further emphasize the caution that, if possible, clinicians should not rely on adherence measures to predict viral suppression. When employed in isolation (without other interventions like reminder mobile short messages), the EM does not provide additional benefit in monitoring treatment adherence and predicting viral suppression.</p>
              <sec id="jia225990-sec-0290">
                <label>5.1</label>
                <title>Strengths and limitations</title>
                <p>Our study followed a large cohort of participants using the Wisepill device for 1 year, which is longer than the follow‐up time for many studies that employed similar technology in ALHIV. Secondly, the study is among a handful of studies that prospectively collected information on various adherence measures in the same cohort of ALHIV concurrently. Hence, we were able to compare the performance of the different adherence measures. Finally, we employed robust statistical methods, including multi‐level logistic regression, to model adherence trends over time. Thus, we dealt with clustering and accounted for the effect of time and the intervention on adherence.</p>
                <p>However, our study has some limitations. It is possible that some participants took their ART without using the Wisepill device, resulting in misclassification bias in adherence. We truncated data from the first week of measuring adherence using the Wisepill device. For some participants, there were multiple signals generated during this period. Excluding data from the first week of monitoring could introduce bias in our study. We experienced several technical challenges, such as interruptions in signal transmission and failure to send a signal due to a drained battery, which resulted in missing data in measuring adherence. To minimize the missed data, our field team followed up through phone calls or physical visits whenever there was a missed signal for more than 3 days. Also, we did not have data on ART resistance and duration of medication, which could have influenced viral suppression. Finally, the results should be generalized cautiously, especially among populations in urban and low HIV burden settings. This is because the study recruited adolescents from HIV care clinics in Makasa subregion, a rural area with an HIV prevalence higher than the national average. In these high HIV burden settings, ALHIV receive comprehensive ART adherence counselling and monitoring from the HIV clinics.</p>
              </sec>
            </sec>
            <sec id="jia225990-sec-0300">
              <label>6</label>
              <title>CONCLUSIONS</title>
              <p>Our findings highlighted the need for strategies to ensure sustained optimal adherence over time. SR and EM measured adherence with a considerable agreement; however, neither was an accurate predictor of virological outcome. There is still a need for an acceptable, feasible and affordable method that predicts viral suppression among ALHIV.</p>
            </sec>
            <sec sec-type="COI-statement" id="jia225990-sec-0310">
              <title>COMPETING INTERESTS</title>
              <p>All authors declare no competing interests.</p>
            </sec>
            <sec id="jia225990-sec-0320">
              <title>AUTHORS’ CONTRIBUTIONS</title>
              <p>FMS, CM and MMM were responsible for fund acquisition. SK, RB, PN, OSB, CM and FMS conceptualized the study. SK, RB, TBN, PN and FMS were responsible for the methodology. CD, OSB, PN and FMS oversaw and supervised data collection. SK, RB, TBN and CD conducted the data analysis. FMS and TN directly accessed and verified the underlying data reported in the manuscript. FN, PN, OSB, AM and FMS were responsible for the study administration and supervision. SK wrote the original draft. RB, TBN, PN, OSB, CD and FMS reviewed and edited the manuscript. All authors participated in the interpretation of data and revising of the manuscript, and the final approval of the manuscript for submission.</p>
            </sec>
            <sec id="jia225990-sec-0340">
              <title>FUNDING</title>
              <p>The Suubi+Adherence study was supported by funding from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), grant number 1R01HD074949–01 (PI: Fred M. Ssewamala).</p>
            </sec>
            <sec id="jia225990-sec-0350">
              <title>DISCLAIMER</title>
              <p>The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NICHD. The funders had no role in any of the stages of preparing this manuscript.</p>
            </sec>
          </body>
          <back>
            <ack id="jia225990-sec-0330">
              <title>ACKNOWLEDGEMENTS</title>
              <p>We thank the study participants and their families for agreeing to participate in the study. We also convey sincere thanks to our implementing partners, including the study clinics, Reach the Youth‐Uganda (RYT) and Masaka diocese. Finally, we thank the ICHAD team based in Uganda for offering field support to ensure that the study was successfully implemented.</p>
            </ack>
            <sec sec-type="data-availability" id="jia225990-sec-0370">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>The datasets included in the analysis for this study are available from the corresponding author on reasonable request.</p>
            </sec>
            <ref-list id="jia225990-bibl-0001">
              <title>REFERENCES</title>
              <ref id="jia225990-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0001"><string-name><surname>Lowenthal</surname><given-names>ED</given-names></string-name>, <string-name><surname>Bakeera‐Kitaka</surname><given-names>S</given-names></string-name>, <string-name><surname>Marukutira</surname><given-names>T</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>J</given-names></string-name>, <string-name><surname>Goldrath</surname><given-names>K</given-names></string-name>, <string-name><surname>Ferrand</surname><given-names>RA</given-names></string-name>. <article-title>Perinatally acquired HIV infection in adolescents from sub‐Saharan Africa: a review of emerging challenges</article-title>. <source>Lancet Infect Dis</source>. <year>2014</year>;<volume>14</volume>(<issue>7</issue>):<fpage>627</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">24406145</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0002"><string-name><surname>Slogrove</surname><given-names>AL</given-names></string-name>, <string-name><surname>Schomaker</surname><given-names>M</given-names></string-name>, <string-name><surname>Davies</surname><given-names>M‐A</given-names></string-name>, <string-name><surname>Williams</surname><given-names>P</given-names></string-name>, <string-name><surname>Balkan</surname><given-names>S</given-names></string-name>, <string-name><surname>Ben‐Farhat</surname><given-names>J</given-names></string-name>, et al. <article-title>The epidemiology of adolescents living with perinatally acquired HIV: a cross‐region global cohort analysis</article-title>. <source>PLoS Med</source>. <year>2018</year>;<volume>15</volume>(<issue>3</issue>):<elocation-id>e1002514</elocation-id>.<pub-id pub-id-type="pmid">29494593</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0003"><string-name><surname>Adejumo</surname><given-names>OA</given-names></string-name>, <string-name><surname>Malee</surname><given-names>KM</given-names></string-name>, <string-name><surname>Ryscavage</surname><given-names>P</given-names></string-name>, <string-name><surname>Hunter</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Taiwo</surname><given-names>BO</given-names></string-name>. <article-title>Contemporary issues on the epidemiology and antiretroviral adherence of HIV‐infected adolescents in sub‐Saharan Africa: a narrative review</article-title>. <source>J Int AIDS Soc</source>. <year>2015</year>;<volume>18</volume>:<elocation-id>20049</elocation-id>.<pub-id pub-id-type="pmid">26385853</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="miscellaneous" id="jia225990-cit-0004"><collab collab-type="authors">UPHIA</collab>
. <article-title>Uganda Population‐Based HIV Impact Assessment 2016–2017</article-title>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0005"><string-name><surname>Tarantino</surname><given-names>N</given-names></string-name>, <string-name><surname>Lowery</surname><given-names>A</given-names></string-name>, <string-name><surname>Brown</surname><given-names>LK</given-names></string-name>. <article-title>Adherence to HIV care and associated health functioning among youth living with HIV in sub‐Saharan Africa</article-title>. <source>AIDS Rev</source>. <year>2020</year>;<volume>22</volume>(<issue>2</issue>):<fpage>93</fpage>–<lpage>102</lpage>.<pub-id pub-id-type="pmid">32180589</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0006"><string-name><surname>Haberer</surname><given-names>JE</given-names></string-name>, <string-name><surname>Kiwanuka</surname><given-names>J</given-names></string-name>, <string-name><surname>Nansera</surname><given-names>D</given-names></string-name>, <string-name><surname>Ragland</surname><given-names>K</given-names></string-name>, <string-name><surname>Mellins</surname><given-names>C</given-names></string-name>, <string-name><surname>Bangsberg</surname><given-names>DR</given-names></string-name>. <article-title>Multiple measures reveal antiretroviral adherence successes and challenges in HIV‐infected Ugandan children</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>5</issue>):<elocation-id>e36737</elocation-id>.<pub-id pub-id-type="pmid">22590600</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="miscellaneous" id="jia225990-cit-0007"><collab collab-type="authors">UNICEF</collab>
. <article-title>HIV and AIDS in adolescents</article-title>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0008"><string-name><surname>Lall</surname><given-names>P</given-names></string-name>, <string-name><surname>Lim</surname><given-names>SH</given-names></string-name>, <string-name><surname>Khairuddin</surname><given-names>N</given-names></string-name>, <string-name><surname>Kamarulzaman</surname><given-names>A</given-names></string-name>. <article-title>Review: an urgent need for research on factors impacting adherence to and retention in care among HIV‐positive youth and adolescents from key populations</article-title>. <source>J Int AIDS Soc</source>. <year>2015</year>;<volume>18</volume>(<issue>2</issue> Suppl 1):<elocation-id>19393</elocation-id>.<pub-id pub-id-type="pmid">25724503</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0009"><string-name><surname>Wiens</surname><given-names>MO</given-names></string-name>, <string-name><surname>MacLeod</surname><given-names>S</given-names></string-name>, <string-name><surname>Musiime</surname><given-names>V</given-names></string-name>, <string-name><surname>Ssenyonga</surname><given-names>M</given-names></string-name>, <string-name><surname>Kizza</surname><given-names>R</given-names></string-name>, <string-name><surname>Bakeera‐Kitaka</surname><given-names>S</given-names></string-name>, et al. <article-title>Adherence to antiretroviral therapy in HIV‐positive adolescents in Uganda assessed by multiple methods: a prospective cohort study</article-title>. <source>Paediatr Drugs</source>. <year>2012</year>;<volume>14</volume>(<issue>5</issue>):<fpage>331</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">22765225</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0010"><string-name><surname>Drain</surname><given-names>PK</given-names></string-name>, <string-name><surname>Kubiak</surname><given-names>RW</given-names></string-name>, <string-name><surname>Siriprakaisil</surname><given-names>O</given-names></string-name>, <string-name><surname>Klinbuayaem</surname><given-names>V</given-names></string-name>, <string-name><surname>Quame‐Amaglo</surname><given-names>J</given-names></string-name>, <string-name><surname>Sukrakanchana</surname><given-names>P‐O</given-names></string-name>, et al. <article-title>Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: a randomized, directly observed pharmacokinetic trial (TARGET Study)</article-title>. <source>Clin Infect Dis</source>. <year>2020</year>;<volume>70</volume>(<issue>10</issue>):<fpage>2143</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">31314073</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0011"><string-name><surname>Abaasa</surname><given-names>A</given-names></string-name>, <string-name><surname>Hendrix</surname><given-names>C</given-names></string-name>, <string-name><surname>Gandhi</surname><given-names>M</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>P</given-names></string-name>, <string-name><surname>Kamali</surname><given-names>A</given-names></string-name>, <string-name><surname>Kibengo</surname><given-names>F</given-names></string-name>, et al. <article-title>Utility of different adherence measures for PrEP: patterns and incremental value</article-title>. <source>AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>4</issue>):<fpage>1165</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">29090394</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0012"><string-name><surname>Velloza</surname><given-names>J</given-names></string-name>, <string-name><surname>Bacchetti</surname><given-names>P</given-names></string-name>, <string-name><surname>Hendrix</surname><given-names>CW</given-names></string-name>, <string-name><surname>Murnane</surname><given-names>P</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>JP</given-names></string-name>, <string-name><surname>Li</surname><given-names>M</given-names></string-name>, et al. <article-title>Short‐ and long‐term pharmacologic measures of HIV pre‐exposure prophylaxis use among high‐risk men who have sex with men in HPTN 067/ADAPT</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2019</year>;<volume>82</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">31335588</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0013"><string-name><surname>Evans</surname><given-names>SD</given-names></string-name>, <string-name><surname>Mellins</surname><given-names>CA</given-names></string-name>, <string-name><surname>Leu</surname><given-names>C‐S</given-names></string-name>, <string-name><surname>Warne</surname><given-names>P</given-names></string-name>, <string-name><surname>Elkington</surname><given-names>KS</given-names></string-name>, <string-name><surname>Dolezal</surname><given-names>C</given-names></string-name>, et al. <article-title>HIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregivers</article-title>. <source>AIDS Patient Care STDs</source>. <year>2015</year>;<volume>29</volume>(<issue>1</issue>):<fpage>43</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">25372391</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0014"><string-name><surname>Burns</surname><given-names>R</given-names></string-name>, <string-name><surname>Magalasi</surname><given-names>D</given-names></string-name>, <string-name><surname>Blasco</surname><given-names>P</given-names></string-name>, <string-name><surname>Szumilin</surname><given-names>E</given-names></string-name>, <string-name><surname>Pasquier</surname><given-names>E</given-names></string-name>, <string-name><surname>Schramm</surname><given-names>B</given-names></string-name>, et al. “<article-title>We give them threatening advice…”: expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi</article-title>. <source>J Int AIDS Soc</source>. <year>2020</year>;<volume>23</volume>(<issue>3</issue>):<elocation-id>e25459</elocation-id>.<pub-id pub-id-type="pmid">32124554</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0015"><string-name><surname>Castillo‐Mancilla</surname><given-names>JR</given-names></string-name>, <string-name><surname>Haberer</surname><given-names>JE</given-names></string-name>. <article-title>Adherence measurements in HIV: new advancements in pharmacologic methods and real‐time monitoring</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2018</year>;<volume>15</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">29380227</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0016"><string-name><surname>Brathwaite</surname><given-names>R</given-names></string-name>, <string-name><surname>Ssewamala</surname><given-names>FM</given-names></string-name>, <string-name><surname>Neilands</surname><given-names>TB</given-names></string-name>, <string-name><surname>Okumu</surname><given-names>M</given-names></string-name>, <string-name><surname>Mutumba</surname><given-names>M</given-names></string-name>, <string-name><surname>Damulira</surname><given-names>C</given-names></string-name>, et al. <article-title>Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study</article-title>. <source>J Int AIDS Soc</source>. <year>2021</year>;<volume>24</volume>(<issue>6</issue>):<elocation-id>e25756</elocation-id>.<pub-id pub-id-type="pmid">34105865</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0017"><string-name><surname>Damulira</surname><given-names>C</given-names></string-name>, <string-name><surname>Mukasa</surname><given-names>MN</given-names></string-name>, <string-name><surname>Byansi</surname><given-names>W</given-names></string-name>, <string-name><surname>Nabunya</surname><given-names>P</given-names></string-name>, <string-name><surname>Kivumbi</surname><given-names>A</given-names></string-name>, <string-name><surname>Namatovu</surname><given-names>P</given-names></string-name>, et al. <article-title>Examining the relationship of social support and family cohesion on ART adherence among HIV‐positive adolescents in southern Uganda: baseline findings</article-title>. <source>Vulnerable Child Youth Stud</source>. <year>2019</year>;<volume>14</volume>(<issue>2</issue>):<fpage>181</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">31149021</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="miscellaneous" id="jia225990-cit-0018"><collab collab-type="authors">UMO Health.</collab><article-title>2021 Factsheet: Facts on HIV and AIDS in Uganda 2021</article-title>. <year>2021</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="miscellaneous" id="jia225990-cit-0019"><collab collab-type="authors">Wisepill</collab>
. <article-title>Medication adherence solutions through innovations</article-title>. <year>2021</year>. Available from: <ext-link xlink:href="https://www.wisepill.com/" ext-link-type="uri">https://www.wisepill.com/</ext-link>. Accessed January 16, 2022.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0020"><string-name><surname>Haberer</surname><given-names>JE</given-names></string-name>, <string-name><surname>Kahane</surname><given-names>J</given-names></string-name>, <string-name><surname>Kigozi</surname><given-names>I</given-names></string-name>, <string-name><surname>Emenyonu</surname><given-names>N</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>P</given-names></string-name>, <string-name><surname>Martin</surname><given-names>J</given-names></string-name>, et al. <article-title>Real‐time adherence monitoring for HIV antiretroviral therapy</article-title>. <source>AIDS Behav</source>. <year>2010</year>;<volume>14</volume>(<issue>6</issue>):<fpage>1340</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">20809380</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="miscellaneous" id="jia225990-cit-0021"><collab collab-type="authors">UMO Health.</collab><article-title>Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda</article-title>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="book" id="jia225990-cit-0022"><collab collab-type="authors">WHO</collab>
. <source>Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2021</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0023"><string-name><surname>Dettori</surname><given-names>JR</given-names></string-name>, <string-name><surname>Norvell</surname><given-names>DC</given-names></string-name>. <article-title>Kappa and beyond: is there agreement?</article-title><source>Global Spine J</source>. <year>2020</year>;<volume>10</volume>(<issue>4</issue>):<fpage>499</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">32435572</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0024"><string-name><surname>Gwet</surname><given-names>KL</given-names></string-name>. <article-title>Computing inter‐rater reliability and its variance in the presence of high agreement</article-title>. <source>Br J Math Stat Psychol</source>. <year>2008</year>;<volume>61</volume>(Pt <issue>1</issue>):<fpage>29</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">18482474</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="book" id="jia225990-cit-0025"><string-name><surname>Hosmer</surname><given-names>DW</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Lemeshow</surname><given-names>S,</given-names></string-name><string-name><surname>Sturdivant</surname><given-names>RX</given-names></string-name>. <source>Applied logistic regression</source>. 3rd ed. <publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley &amp; Sons, Inc</publisher-name>; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0026"><string-name><surname>Mboup</surname><given-names>A</given-names></string-name>, <string-name><surname>Béhanzin</surname><given-names>L</given-names></string-name>, <string-name><surname>Guédou</surname><given-names>F</given-names></string-name>, <string-name><surname>Giguère</surname><given-names>K</given-names></string-name>, <string-name><surname>Geraldo</surname><given-names>N</given-names></string-name>, <string-name><surname>Zannou</surname><given-names>DM</given-names></string-name>, et al. <article-title>Comparison of adherence measurement tools used in a pre‐exposure prophylaxis demonstration study among female sex workers in Benin</article-title>. <source>Medicine (Baltimore)</source>. <year>2020</year>;<volume>99</volume>(<issue>21</issue>):<elocation-id>e20063</elocation-id>.<pub-id pub-id-type="pmid">32481273</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0027"><string-name><surname>Koss</surname><given-names>CA</given-names></string-name>, <string-name><surname>Hosek</surname><given-names>SG</given-names></string-name>, <string-name><surname>Bacchetti</surname><given-names>P</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>PL</given-names></string-name>, <string-name><surname>Liu</surname><given-names>AY</given-names></string-name>, <string-name><surname>Horng</surname><given-names>H</given-names></string-name>, et al. <article-title>Comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the United States</article-title>. <source>Clin Infect Dis</source>. <year>2018</year>;<volume>66</volume>(<issue>2</issue>):<fpage>213</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">29020194</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0028"><string-name><surname>Firdu</surname><given-names>N</given-names></string-name>, <string-name><surname>Enquselassie</surname><given-names>F</given-names></string-name>, <string-name><surname>Jerene</surname><given-names>D</given-names></string-name>. <article-title>HIV‐infected adolescents have low adherence to antiretroviral therapy: a cross‐sectional study in Addis Ababa, Ethiopia</article-title>. <source>Pan Afr Med J</source>. <year>2017</year>;<volume>27</volume>:<fpage>80</fpage>.<pub-id pub-id-type="pmid">28819501</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0029"><string-name><surname>Meloni</surname><given-names>ST</given-names></string-name>, <string-name><surname>Agaba</surname><given-names>P</given-names></string-name>, <string-name><surname>Chang</surname><given-names>CA</given-names></string-name>, <string-name><surname>Yiltok</surname><given-names>E</given-names></string-name>, <string-name><surname>Oguche</surname><given-names>S</given-names></string-name>, <string-name><surname>Ejeliogu</surname><given-names>E</given-names></string-name>, et al. <article-title>Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria</article-title>. <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>7</issue>):<elocation-id>e0236801</elocation-id>.<pub-id pub-id-type="pmid">32735566</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0030"><string-name><surname>Vreeman</surname><given-names>RC</given-names></string-name>, <string-name><surname>Scanlon</surname><given-names>ML</given-names></string-name>, <string-name><surname>Tu</surname><given-names>W</given-names></string-name>, <string-name><surname>Slaven</surname><given-names>JE</given-names></string-name>, <string-name><surname>McAteer</surname><given-names>CI</given-names></string-name>, <string-name><surname>Kerr</surname><given-names>SJ</given-names></string-name>, et al. <article-title>Validation of a self‐report adherence measurement tool among a multinational cohort of children living with HIV in Kenya, South Africa and Thailand</article-title>. <source>J Int AIDS Soc</source>. <year>2019</year>;<volume>22</volume>(<issue>5</issue>):<elocation-id>e25304</elocation-id>.<pub-id pub-id-type="pmid">31148372</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0031"><string-name><surname>Prasitsuebsai</surname><given-names>W</given-names></string-name>, <string-name><surname>Sethaputra</surname><given-names>C</given-names></string-name>, <string-name><surname>Lumbiganon</surname><given-names>P</given-names></string-name>, <string-name><surname>Hansudewechakul</surname><given-names>R</given-names></string-name>, <string-name><surname>Chokephaibulkit</surname><given-names>K</given-names></string-name>, <string-name><surname>Truong</surname><given-names>KH</given-names></string-name>, et al. <article-title>Adherence to antiretroviral therapy, stigma and behavioral risk factors in HIV‐infected adolescents in Asia</article-title>. <source>AIDS Care</source>. <year>2018</year>;<volume>30</volume>(<issue>6</issue>):<fpage>727</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">29336591</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0032"><string-name><surname>Nabukeera‐Barungi</surname><given-names>N</given-names></string-name>, <string-name><surname>Elyanu</surname><given-names>P</given-names></string-name>, <string-name><surname>Asire</surname><given-names>B</given-names></string-name>, <string-name><surname>Katureebe</surname><given-names>C</given-names></string-name>, <string-name><surname>Lukabwe</surname><given-names>I</given-names></string-name>, <string-name><surname>Namusoke</surname><given-names>E</given-names></string-name>, et al. <article-title>Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda</article-title>. <source>BMC Infect Dis</source>. <year>2015</year>;<volume>15</volume>:<fpage>520</fpage>.<pub-id pub-id-type="pmid">26573923</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0033"><string-name><surname>Orrell</surname><given-names>C</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>K</given-names></string-name>, <string-name><surname>Leisegang</surname><given-names>R</given-names></string-name>, <string-name><surname>Bangsberg</surname><given-names>DR</given-names></string-name>, <string-name><surname>Wood</surname><given-names>R</given-names></string-name>, <string-name><surname>Maartens</surname><given-names>G</given-names></string-name>. <article-title>Comparison of six methods to estimate adherence in an ART‐naïve cohort in a resource‐poor setting: which best predicts virological and resistance outcomes?</article-title><source>AIDS Res Ther</source>. <year>2017</year>;<volume>14</volume>(<issue>1</issue>):<fpage>20</fpage>.<pub-id pub-id-type="pmid">28376815</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0034"><string-name><surname>Usitalo</surname><given-names>A</given-names></string-name>, <string-name><surname>Leister</surname><given-names>E</given-names></string-name>, <string-name><surname>Tassiopoulos</surname><given-names>K</given-names></string-name>, <string-name><surname>Allison</surname><given-names>S</given-names></string-name>, <string-name><surname>Malee</surname><given-names>K</given-names></string-name>, <string-name><surname>Paul</surname><given-names>ME</given-names></string-name>, et al. <article-title>Relationship between viral load and self‐report measures of medication adherence among youth with perinatal HIV infection</article-title>. <source>AIDS Care</source>. <year>2014</year>;<volume>26</volume>(<issue>1</issue>):<fpage>107</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">23800360</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0035"><string-name><surname>Da</surname><given-names>W</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Qiao</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Z</given-names></string-name>. <article-title>Evaluation of self‐report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>8</issue>):<elocation-id>e0203032</elocation-id>.<pub-id pub-id-type="pmid">30161177</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0036"><string-name><surname>Natukunda</surname><given-names>J</given-names></string-name>, <string-name><surname>Kirabira</surname><given-names>P</given-names></string-name>, <string-name><surname>Ong</surname><given-names>KIC</given-names></string-name>, <string-name><surname>Shibanuma</surname><given-names>A</given-names></string-name>, <string-name><surname>Jimba</surname><given-names>M</given-names></string-name>. <article-title>Virologic failure in HIV‐positive adolescents with perfect adherence in Uganda: a cross‐sectional study</article-title>. <source>Trop Med Health</source>. <year>2019</year>;<volume>47</volume>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0037"><string-name><surname>Gordon</surname><given-names>LL</given-names></string-name>, <string-name><surname>Gharibian</surname><given-names>D</given-names></string-name>, <string-name><surname>Chong</surname><given-names>K</given-names></string-name>, <string-name><surname>Chun</surname><given-names>H</given-names></string-name>. <article-title>Comparison of HIV virologic failure rates between patients with variable adherence to three antiretroviral regimen types</article-title>. <source>AIDS Patient Care STDs</source>. <year>2015</year>;<volume>29</volume>(<issue>7</issue>):<fpage>384</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">26114665</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0038"><string-name><surname>Madiba</surname><given-names>S</given-names></string-name>, <string-name><surname>Josiah</surname><given-names>U</given-names></string-name>. <article-title>Perceived stigma and fear of unintended disclosure are barriers in medication adherence in adolescents with perinatal HIV in Botswana: a qualitative study</article-title>. <source>Biomed Res Int</source>. <year>2019</year>;<volume>2019</volume>:<elocation-id>9623159</elocation-id>.<pub-id pub-id-type="pmid">31886271</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0039"><string-name><surname>Denison</surname><given-names>JA</given-names></string-name>, <string-name><surname>Packer</surname><given-names>C</given-names></string-name>, <string-name><surname>Stalter</surname><given-names>RM</given-names></string-name>, <string-name><surname>Banda</surname><given-names>H</given-names></string-name>, <string-name><surname>Mercer</surname><given-names>S</given-names></string-name>, <string-name><surname>Nyambe</surname><given-names>N</given-names></string-name>, et al. <article-title>Factors related to incomplete adherence to antiretroviral therapy among adolescents attending three HIV clinics in the Copperbelt, Zambia</article-title>. <source>AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>3</issue>):<fpage>996</fpage>–<lpage>1005</lpage>.<pub-id pub-id-type="pmid">29103190</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0040"><string-name><surname>Yildirim</surname><given-names>C</given-names></string-name>, <string-name><surname>Garvie</surname><given-names>PA</given-names></string-name>, <string-name><surname>Chernoff</surname><given-names>M</given-names></string-name>, <string-name><surname>Wilkins</surname><given-names>ML</given-names></string-name>, <string-name><surname>Patton</surname><given-names>ED</given-names></string-name>, <string-name><surname>Williams</surname><given-names>PL</given-names></string-name>, et al. <article-title>The role of pharmacy refill measures in assessing adherence and predicting HIV disease markers in youth with perinatally‐acquired HIV (PHIV)</article-title>. <source>AIDS Behav</source>. <year>2019</year>;<volume>23</volume>(<issue>8</issue>):<fpage>2109</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">30929147</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0041"><string-name><surname>Gichane</surname><given-names>MW</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>KA</given-names></string-name>, <string-name><surname>Shayo</surname><given-names>AM</given-names></string-name>, <string-name><surname>Mmbaga</surname><given-names>BT</given-names></string-name>, <string-name><surname>O’ Donnell</surname><given-names>K</given-names></string-name>, <string-name><surname>Cunningham</surname><given-names>CK</given-names></string-name>, et al. <article-title>Caregiver role in HIV medication adherence among HIV‐infected orphans in Tanzania</article-title>. <source>AIDS Care</source>. <year>2018</year>;<volume>30</volume>(<issue>6</issue>):<fpage>701</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">29058461</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0042"><string-name><surname>MacCarthy</surname><given-names>S</given-names></string-name>, <string-name><surname>Saya</surname><given-names>U</given-names></string-name>, <string-name><surname>Samba</surname><given-names>C</given-names></string-name>, <string-name><surname>Birungi</surname><given-names>J</given-names></string-name>, <string-name><surname>Okoboi</surname><given-names>S</given-names></string-name>, <string-name><surname>Linnemayr</surname><given-names>S</given-names></string-name>. <article-title>“How am I going to live?”: exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda</article-title>. <source>BMC Public Health</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1158</fpage>.<pub-id pub-id-type="pmid">30286746</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0043"><string-name><surname>Nabunya</surname><given-names>P</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>OS</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B</given-names></string-name>, <string-name><surname>Dvalishvili</surname><given-names>D</given-names></string-name>, <string-name><surname>Damulira</surname><given-names>C</given-names></string-name>, <string-name><surname>Ssewamala</surname><given-names>FM</given-names></string-name>. <article-title>The role of family factors in antiretroviral therapy (ART) adherence self‐efficacy among HIV‐infected adolescents in southern Uganda</article-title>. <source>BMC Public Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>340</fpage>.<pub-id pub-id-type="pmid">32183762</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0044"><string-name><surname>Ssewamala</surname><given-names>FM</given-names></string-name>, <string-name><surname>Byansi</surname><given-names>W</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>OS</given-names></string-name>, <string-name><surname>Nabunya</surname><given-names>P</given-names></string-name>, <string-name><surname>Neilands</surname><given-names>TB</given-names></string-name>, <string-name><surname>Mellins</surname><given-names>C</given-names></string-name>, et al. <article-title>Suubi+Adherence study protocol: a family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents</article-title>. <source>Contemp Clin Trials Commun</source>. <year>2019</year>;<volume>16</volume>:<elocation-id>100463</elocation-id>.<pub-id pub-id-type="pmid">31872152</pub-id></mixed-citation>
              </ref>
              <ref id="jia225990-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0045"><string-name><surname>Gaifer</surname><given-names>Z</given-names></string-name>, <string-name><surname>Boulassel</surname><given-names>MR</given-names></string-name>. <article-title>Comparative analysis of two methods of measuring antiretroviral therapy adherence in HIV‐infected Omani patients</article-title>. <source>J Int Assoc Provid AIDS Care</source>. <year>2019</year>;<volume>18</volume>.</mixed-citation>
              </ref>
              <ref id="jia225990-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="jia225990-cit-0046"><string-name><surname>Arnsten</surname><given-names>JH</given-names></string-name>, <string-name><surname>Demas</surname><given-names>PA</given-names></string-name>, <string-name><surname>Farzadegan</surname><given-names>H</given-names></string-name>, <string-name><surname>Grant</surname><given-names>RW</given-names></string-name>, <string-name><surname>Gourevitch</surname><given-names>MN</given-names></string-name>, <string-name><surname>Chang</surname><given-names>C</given-names></string-name>, et al. <article-title>Antiretroviral therapy adherence and viral suppression in HIV‐infected drug users: comparison of self‐report and electronic monitoring</article-title>. <source>Clin Infect Dis</source>. <year>2001</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1417</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">11550118</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
